Angiotensin-Converting Enzyme InhibitorsEflornithineOrnithine DecarboxylaseOrnithineAlkynesPolyaminesDiaminesPutrescineSubstrate SpecificityKineticsEnzyme InhibitorsEnalaprilDiazomethaneCaptoprilAdenosylmethionine DecarboxylaseCarboxy-LyasesSpermidine4-Aminobutyrate TransaminaseVigabatrinAminopropionitrileBiogenic PolyaminesCysteine Proteinase InhibitorsLisinoprilAminocaproatesBinding SitesLeukemia L1210Monoamine Oxidase InhibitorsMolecular Sequence DataAngiotensin Receptor AntagonistsAmino Acid SequenceEpoxy CompoundsSperminePerindoprilEnalaprilatDeoxyadenosinesClorgylineProtein-Lysine 6-OxidaseAntihypertensive AgentsStructure-Activity RelationshipRamiprilAngiotensin II Type 1 Receptor BlockersModels, MolecularDose-Response Relationship, DrugCilazaprilNitro CompoundsMitoguazoneMolecular StructureTeprotideCatalysisAniline CompoundsRenin-Angiotensin SystemCystathionine gamma-LyaseCatalytic DomainHypertensionOligopeptidesEscherichia coliCholinesterase InhibitorsCrystallography, X-RayCysteine EndopeptidasesIsoflurophateTime FactorsPsoralensThiazepinesDrug DesignBlood PressureProtein BindingStereoisomerismPropionatesReninAcetylcholinesteraseTetrazolesChromatography, High Pressure LiquidSerine Proteinase InhibitorsInhibitory Concentration 50DiureticsCysteineAdrenergic beta-AntagonistsIsoxazolesCattleDrug Evaluation, PreclinicalMonoamine OxidaseImidazolidinesTetrahydroisoquinolinesRecombinant ProteinsOxidation-ReductionCell LineAngioedemaEnzyme ActivationAmino Acid Chloromethyl KetonesLiverRats, Sprague-DawleyAntineoplastic Agents3-Mercaptopropionic AcidLosartanCells, CulturedBradykininAngiotensin IIHeart FailureMutationPeptidyl-Dipeptidase A